Skip to main content

Table 3 Multivariate analysis results for overall survival rate of cervical cancer patients using the Cox multiple regression method

From: Californium-252 neutron brachytherapy combined with external pelvic radiotherapy plus concurrent chemotherapy for cervical cancer: a retrospective clinical study

Characteristic P value HR 95% CI
Stage (FIGO)
 III vs. I–II 0.398 0.63 0.21–1.85
 IV vs. I–II 0.271 2.14 0.55–8.28
Pre-treatment tumor size (≤4.0 cm vs. >4.0 cm) 0.908 3.11 0.82–7.90
Lymph node metastasis (yes vs. no) 0.001 36.32 4.65–283.92
  1. Patients with unknown lymph node status were excluded from the multivariate analysis with the characteristic of lymph node metastasis
  2. HR hazard ratio, CI confidence interval, FIGO International Federation of Gynecology and Obstetrics